MAIA Biotechnology, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureOct 6 →Insiders7 insiders bought $985,983 in 27 open-market buys. No sales.→HoldersSolas 5.0%Alyeska Investment 4.1%Vanguard 4.0%→Financing →PeersClosest companies: ERAS, IDYA, PYXS→
From the filings
Figures
- Net income
- −$26.8Mlast 12 months
- Operating cash flow
- −$20.0Mlast 12 months
- Cash and equivalents
- $0.00at the last balance sheet
- Shares outstanding
- 60.8M shareson issue